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Abstract
Background: Since the stage of cancer detection generally predicts future mortality rates, a key
cancer control strategy is to increase the proportion of cancers found in the early stage. This study
compared stage of detection for members of rural and urban communities to determine whether
disparities were present.
Methods: The California Cancer Registry (CCR), a total population based cancer registry, was
used to examine the proportion of early stage presentation for patients with breast, melanoma, and
colon cancer from 1988 to 2003. Cancer stage at time of detection for these cancers was compared
for rural and urban areas.
Results: In patients with breast cancer, there were significantly more patients presenting at early
stage in 2003 compared to 1988, but no difference in the percentage of patients presenting with
early stage disease between rural and urban dwellers. There were no differences in incidence in
early stage cancer incidence between these groups for melanoma patients, as well. In colorectal
cancer in 1988, significantly more patients presented with early stage disease in the urban areas
(42% vs 34%, p < 0.02). However, over time the rural patients were diagnosed with early stage
disease with the same frequency in 2003 as 1988.
Conclusion: This analysis demonstrates that people in rural and urban areas have their breast,
melanoma or colorectal cancers diagnosed at similar stages. Health care administrators may take
this information into account in future strategic planning.
Background
Addressing identified pockets of health disparities within
various population sub-groups has become a major focus
among leading cancer organizations as they work toward
achieving their cancer control goals [1,2]. Researchers
have identified health disparities among economic groups
[3], ethnic groups [4], sexual identity groups [5], socioeco-
nomic groups [6], genders [7] and geographic locations,
such as urban verses rural [8,9]. Stage of diagnosis is the
single best predictor of cancer morbidity and mortality.
This study used data from the California Cancer Registry
to test whether differences exist in the stage of cancer diag-
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nosis between rural areas and urban areas. Knowing
where differences in stage of cancer diagnosis exist can
help health policy makers and educators plan more effec-
tive cancer control interventions.
Previous studies have identified significant disparities in
stages of diagnosis between people living in rural and
urban areas, with a greater incidence of late stage diagno-
sis generally found in rural areas [10][11]. This has been
attributed to limited access to clinics and hospitals with
the advanced technology needed to detect cancer in the
early stage and may need to travel great distances to
receive care [12]. Lack of insurance available to individu-
als that reside in rural areas is another problem for these
patients [13]. In addition, members of rural communities
may lack basic cancer information because they do not
have the same access to cancer education programs that
are offered in urban areas [14]. At least one study suggests
that physicians in the rural community may not encour-
age screening as strongly as physicians living in urban
communities [14]. The authors of this study did not inter-
view physicians to find out the cause for this difference
but rural women were less likely to undergo a clinical
breast exam and be referred for a screening mammogram
[14].
While these factors are reported to contribute to a higher
rate of late stage cancer detection in rural versus urban
areas, a study by McElroy found no significant difference
in early detection of cancer between urban and rural com-
munities [15]. He attributed this lack of observed dispar-
ity to the fact that the use of technology has expanded,
and more women living in rural areas are receiving screen-
ing [15]. With these conflicting results in the literature, the
aim of this study was to examine whether discrepancies in
the rates of diagnosis of early stage cancers could be found
among patients in the California Cancer Registry (CCR).
Methods
In 1988, cancer was made a mandatory reportable disease
in California. The California Cancer Registry (CCR)
became the repository for the data. New cases are reported
by physicians, health facilities, laboratories, and death
certificates, and there are penalties for failure to report
cases. The actual abstracting of cases is done by certified
Cancer Abstracters. Ten Regional Cancer Registries were
set up to act as the first-level receiving facility and to pro-
vide quality assurance, coordination of reports from mul-
tiple sources for the same patient, provide technical help
to those reporting cases, and then to report the data to the
central registry in Sacramento. At this level, there is further
quality assurance, elimination of duplicate entries, clear-
ance with death certificates, and mutual referral of reports
of patients actually residing in other states and countries.
The CCR is certified by the North American Association of
Central Cancer Registries (NAACCR) and currently the
entire state is part of NCI's Surveillance, Epidemiology,
and End Results Program (SEER). California has the larg-
est population of any single total population-based regis-
try in the world.
With California's very large population (36 million in
2003), CCR is the total population-based registry encom-
passing the largest population in the world, and probably,
the most diverse. Sixteen years of data (2,387,316 individ-
ual cancers), with all patient, physician, and institutional
identification removed, are available to researchers.
The data set includes demographics of the patient, fea-
tures of the tumor such as stage and histology, and follow-
up information. The data are made available to qualified
researchers on a CD. Intercensal population data devel-
oped by the California Department of Finance have been
supplied by the CCR.
There are no uniformly accepted definitions of "rural" and
"urban" for registry data. We have chosen the one used by
the California Rural Health Commission [16], using
counties as the areas of interest. "Rural" counties are those
with a population density of 250 people or less per square
mile and no incorporated communities of more than
50,000 people. Using this definition, we identified 28
"rural" counties (population density range 1.56 to 98.2
people/sq. mi.) having a total population of 1,842,118.
For an "urban" comparison group, we selected the two
counties with the highest population densities (3,488.58
and 17,213.49) people per square mile and which contain
4,476,251 people), rather than those with the largest pop-
ulations, leaving 28 other counties in a "mixed" category
and not further studied. Since we do not have the patients'
actual addresses, socioeconomic data and because these,
as well as facilities, transportation, effects of educational
programs, the role of mobile mammographic facilities,
etc., often change with time, we cannot evaluate what part
may be played by any of these. Moreover, one must be
aware that even in the two groups, there may be county-
to-county differences.
Using the above definitions of "rural" and "urban", all of
the cases which had the years of diagnosis and Summary
Stage of breast cancer, colorectal cancer, and cutaneous
malignant melanoma from the years 1988 through 2003
were studied. For each type of cancer, data were tabulated
by years of diagnosis and "early" versus "late" stage, using
the "EpiInfo6" (CDC and WHO) software. As noted
above, there are multiple levels of quality assurance, and
the standards of the North American Association of Cen-
tral Cancer Registries (NAACCR) are all met or exceeded.
The tissue diagnoses of the original pathologists are
accepted because central review would be a fiscal andBMC Public Health 2006, 6:194 http://www.biomedcentral.com/1471-2458/6/194
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operational impossibility. It should be remembered that
the patient's therapy is based on the diagnosis by the local
pathologist.
Early" stage is defined as a Summary Stage of carcinoma-
in-situ or localized tumor, and "late" stage is a Summary
Stage of regional or distant disease. Summary Stages are
rigorously defined by the NCI's Surveillance, Epidemiol-
ogy, and End Results Program (SEER), the American Joint
Commission on Cancer, and the American College of Sur-
geons. The definitions of stages differ from one primary
site to another. While for clinical purposes it might be
preferable to use the TNM System, there are no TNM stag-
ing data for the earlier years of CCR for all sites and thus
not possible to use the TNM system. Moreover, to allow
comparison with earlier registry data as well as data from
other registries, the Summary Stage is more useful. When
the data exist, cross- tabulations of Summary Stage "local-
ized" against "T1N0M0" show a correlation of over 90%.
We do not have data on Breslow stage. Staging data are
not available for every case. Finally, while the CCR has
information about ethnicity, there are not enough num-
bers in the non-white rural population to draw any mean-
ingful conclusions to include in this manuscript. Because
this study used the above data, it was exempt from the
usual methods of Ethical Approval.
Results
Using the above definitions of rural and urban, the 28
rural counties were compared to the two urban counties
with the greatest population density. Between 1988 and
2003 there were 59,615 total breast cancers in the registry
and 19,428 were in rural patients and 40,187 were in
urban patients. There were significantly more patients pre-
senting at early summary stage in 2003 compared to 1988
(71 % vs. 65%, p < 0.007). However, there was no differ-
ence in percentage of patients presenting with early sum-
mary stage disease between rural and urban dwellers. For
example, in 2003, 70% of urban patients presented with
early summary stage disease and 69% of urban patients
were diagnosed with early summary stage breast cancer.
(Figure 1)
In patients with cutaneous melanoma there were 15,793
total cases in the registry. Rural patients had 5,149
melanomas and urban patients had 10,644; however,
there was no difference in summary stage of diagnosis
over time. Likewise, there was no difference between rural
or urban dwellers in summary stage of diagnosis. In the
state of California, an average of 93% of patients present
with early summary stage melanoma (Figure 2.)
For colorectal cancer between 1988 and 2003 there were
26,481 cases recorded. Rural patients had 7,999 cases and
urban patients had 18,482 cases. In 1988, significantly
more patients presented with early summary stage disease
in the urban areas (42% vs 34%, p < 0.02). However, over
time the rural patients were diagnosed with early sum-
mary stage disease with the same frequency and in 2003,
there was no difference in percentage of patients with
early summary stage disease (41% vs. 44% P = 0.1, Figure
3).
Cutaneous Melanoma Rural vs. Urban Figure 2
Cutaneous Melanoma Rural vs. Urban. This graph com-
pares the percent of early stage melanomas in patients in 
both urban and rural locations over time from 1988 to 2003 
from the California Cancer Registry.
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Early Breast Cancer Rural vs. Urban Figure 1
Early Breast Cancer Rural vs. Urban. This graph com-
pares the percent of early breast cancers in rural and urban 
patients over time from 1988 to 2003 in the California Can-
cer Registry.
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Discussion
While health care services are widely available in the
United States, access to those services varies widely. Rural-
urban differences have been postulated. Financial access
to health care is deemed to be a problem for many Amer-
ican who are uninsured or underinsured. Language and
cultural barriers can be equally powerful barriers. Health
policy planners must carefully consider where to put
health care dollars for maximum benefit. Given that
detecting early stage cancers is usually better for patients
and usually costs less for providers, the central public
health goal is to prevent cancers or detect early stage can-
cers.
In the past, investigators have reported that rural patients
had less access to screening modalities and were less likely
to present with early stage cancers compared to urban
patients. The best studied group is screening women for
breast cancer. One recent study has shown a possible
reversal in this trend. McElroy et al reported on over 4000
women in Wisconsin diagnosed with breast cancer from
1981–2000. There was an increase incidence of pre-inva-
sive cancer diagnosis and an increase mammography
screening in women residing in rural areas [15]. Although
this is an important report other data in other parts of the
country is needed to confirm theses findings.
Furthermore, Santora el al found in Florida that rural
practitioners were more likely to use written breast cancer
guidelines compared to urban practitioners [17]. The data
from this study confirms McElroy et al.'s finding that there
was an increase of diagnosis of early stage breast cancer
and likewise there was no difference between rural and
urban populations.
In addition, this study confirmed that there were no dif-
ferences in diagnosis of early stage cancer between these
groups for melanoma patients as well. There is little data
on influence of location (rural vs. urban) on the incidence
of early stage melanoma. Van Durme et al. examined the
database from the State of Florida and found that lower
median educational attainment but not rural verses urban
residence increased the risk of presenting with late-stage
disease [18]. This study's data did not find any difference
in incidence of earlier stage melanomas from 1988 to
2003. This is similar to results seen by Brackeen et al. in
which they found no difference in incidence of thinner
melanomas in the state of Texas between 1980 and 2000
despite public education [19].
Lastly, this study did find, like other previous investiga-
tors, that there were more locally advanced cancers in
rural areas for colorectal cancer in the early period which
may reflect less availability of practitioners and technol-
ogy for screening. However, in the last few years that trend
has reversed and there is no difference in incidence of
early stage cancers for colorectal cancer as well. Other
recent investigators have found that socio-economic sta-
tus is a more important determinant of early stage disease
than rural or urban residence. For example, recent publi-
cations concerning these issues in Florida found that soci-
oeconomic status predicted advanced stage disease, but
not rural residence and Koka et al. found that in North
Dakota distance from a tertiary care center did not seem to
be a barrier to early diagnosis of colorectal cancer[20,21].
Conclusion
At present in California, the California Cancer Registry
data demonstrate that people in rural and urban areas
have their cancers diagnosed at comparable stages. Health
care administrators may take this information into
account in future strategic planning.
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Colorectal Carcinoma Rural vs Urban Figure 3
Colorectal Carcinoma Rural vs Urban. This graph com-
pares the percent of early stage colorectal cancers in both 
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